25 Years of the GERD-HRQL symptom severity instrument: an assessment of published applications
Background The GERD-HRQL symptom severity instrument was developed and published 25 years ago. This seems like an apropos time to review how the instrument has been used in the “real-world.” Methods Google Scholar, PubMed, and Web of Science websites search was done using the keywords “GERD-HRQL” or...
Saved in:
Published in | Surgical endoscopy Vol. 37; no. 1; pp. 255 - 265 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.01.2023
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
The GERD-HRQL symptom severity instrument was developed and published 25 years ago. This seems like an apropos time to review how the instrument has been used in the “real-world.”
Methods
Google Scholar, PubMed, and Web of Science websites search was done using the keywords “GERD-HRQL” or its author, “Velanovich.” Once articles were identified, the following information was obtained from each article: first author name, country of origin, journal published, year of publications, type of study design, subject of study, category of study, disease type studied, purpose of the study, how the GERD-HRQL scores were reported, how the GERD-HRQL scores were statistically reported, and results of the study. The total and change of scores were analyzed for descriptive statistics based on disease process studied and intervention studied.
Results
A total of 767 articles by 562 different first authors were identified in 193 different journals from 53 different countries of study origin. After a period of steady usages, the number of publication employing the GERD-HRQL has rapidly increase over the last 5 years. There have been 8 validated translations into other languages, although there appears to be numerous, non-validated ad hoc translations. Most commonly used or studied: observational cohort study design, surgical treatment study category, GERD disease process, treatment effect study purpose, total GERD-HRQL scores reported as means or medians. However, there were a wide variety of other study designs, study categories, disease processes, and study purposes. In general, GERD and laryngopharyngeal reflux had the high pre-treatment scores (i.e., more severe symptoms), and surgical and endoscopic interventions the lowest post-treatment score (i.e., least severe symptoms) with the largest change in score (i.e., treatment impact.
Conclusions
The GERD-HRQL has proven to be a reliable, responsive and versatile symptom severity instrument for studies involving GERD as a subject. |
---|---|
AbstractList | BackgroundThe GERD-HRQL symptom severity instrument was developed and published 25 years ago. This seems like an apropos time to review how the instrument has been used in the “real-world.”MethodsGoogle Scholar, PubMed, and Web of Science websites search was done using the keywords “GERD-HRQL” or its author, “Velanovich.” Once articles were identified, the following information was obtained from each article: first author name, country of origin, journal published, year of publications, type of study design, subject of study, category of study, disease type studied, purpose of the study, how the GERD-HRQL scores were reported, how the GERD-HRQL scores were statistically reported, and results of the study. The total and change of scores were analyzed for descriptive statistics based on disease process studied and intervention studied.ResultsA total of 767 articles by 562 different first authors were identified in 193 different journals from 53 different countries of study origin. After a period of steady usages, the number of publication employing the GERD-HRQL has rapidly increase over the last 5 years. There have been 8 validated translations into other languages, although there appears to be numerous, non-validated ad hoc translations. Most commonly used or studied: observational cohort study design, surgical treatment study category, GERD disease process, treatment effect study purpose, total GERD-HRQL scores reported as means or medians. However, there were a wide variety of other study designs, study categories, disease processes, and study purposes. In general, GERD and laryngopharyngeal reflux had the high pre-treatment scores (i.e., more severe symptoms), and surgical and endoscopic interventions the lowest post-treatment score (i.e., least severe symptoms) with the largest change in score (i.e., treatment impact.ConclusionsThe GERD-HRQL has proven to be a reliable, responsive and versatile symptom severity instrument for studies involving GERD as a subject. The GERD-HRQL symptom severity instrument was developed and published 25 years ago. This seems like an apropos time to review how the instrument has been used in the "real-world."BACKGROUNDThe GERD-HRQL symptom severity instrument was developed and published 25 years ago. This seems like an apropos time to review how the instrument has been used in the "real-world."Google Scholar, PubMed, and Web of Science websites search was done using the keywords "GERD-HRQL" or its author, "Velanovich." Once articles were identified, the following information was obtained from each article: first author name, country of origin, journal published, year of publications, type of study design, subject of study, category of study, disease type studied, purpose of the study, how the GERD-HRQL scores were reported, how the GERD-HRQL scores were statistically reported, and results of the study. The total and change of scores were analyzed for descriptive statistics based on disease process studied and intervention studied.METHODSGoogle Scholar, PubMed, and Web of Science websites search was done using the keywords "GERD-HRQL" or its author, "Velanovich." Once articles were identified, the following information was obtained from each article: first author name, country of origin, journal published, year of publications, type of study design, subject of study, category of study, disease type studied, purpose of the study, how the GERD-HRQL scores were reported, how the GERD-HRQL scores were statistically reported, and results of the study. The total and change of scores were analyzed for descriptive statistics based on disease process studied and intervention studied.A total of 767 articles by 562 different first authors were identified in 193 different journals from 53 different countries of study origin. After a period of steady usages, the number of publication employing the GERD-HRQL has rapidly increase over the last 5 years. There have been 8 validated translations into other languages, although there appears to be numerous, non-validated ad hoc translations. Most commonly used or studied: observational cohort study design, surgical treatment study category, GERD disease process, treatment effect study purpose, total GERD-HRQL scores reported as means or medians. However, there were a wide variety of other study designs, study categories, disease processes, and study purposes. In general, GERD and laryngopharyngeal reflux had the high pre-treatment scores (i.e., more severe symptoms), and surgical and endoscopic interventions the lowest post-treatment score (i.e., least severe symptoms) with the largest change in score (i.e., treatment impact.RESULTSA total of 767 articles by 562 different first authors were identified in 193 different journals from 53 different countries of study origin. After a period of steady usages, the number of publication employing the GERD-HRQL has rapidly increase over the last 5 years. There have been 8 validated translations into other languages, although there appears to be numerous, non-validated ad hoc translations. Most commonly used or studied: observational cohort study design, surgical treatment study category, GERD disease process, treatment effect study purpose, total GERD-HRQL scores reported as means or medians. However, there were a wide variety of other study designs, study categories, disease processes, and study purposes. In general, GERD and laryngopharyngeal reflux had the high pre-treatment scores (i.e., more severe symptoms), and surgical and endoscopic interventions the lowest post-treatment score (i.e., least severe symptoms) with the largest change in score (i.e., treatment impact.The GERD-HRQL has proven to be a reliable, responsive and versatile symptom severity instrument for studies involving GERD as a subject.CONCLUSIONSThe GERD-HRQL has proven to be a reliable, responsive and versatile symptom severity instrument for studies involving GERD as a subject. Background The GERD-HRQL symptom severity instrument was developed and published 25 years ago. This seems like an apropos time to review how the instrument has been used in the “real-world.” Methods Google Scholar, PubMed, and Web of Science websites search was done using the keywords “GERD-HRQL” or its author, “Velanovich.” Once articles were identified, the following information was obtained from each article: first author name, country of origin, journal published, year of publications, type of study design, subject of study, category of study, disease type studied, purpose of the study, how the GERD-HRQL scores were reported, how the GERD-HRQL scores were statistically reported, and results of the study. The total and change of scores were analyzed for descriptive statistics based on disease process studied and intervention studied. Results A total of 767 articles by 562 different first authors were identified in 193 different journals from 53 different countries of study origin. After a period of steady usages, the number of publication employing the GERD-HRQL has rapidly increase over the last 5 years. There have been 8 validated translations into other languages, although there appears to be numerous, non-validated ad hoc translations. Most commonly used or studied: observational cohort study design, surgical treatment study category, GERD disease process, treatment effect study purpose, total GERD-HRQL scores reported as means or medians. However, there were a wide variety of other study designs, study categories, disease processes, and study purposes. In general, GERD and laryngopharyngeal reflux had the high pre-treatment scores (i.e., more severe symptoms), and surgical and endoscopic interventions the lowest post-treatment score (i.e., least severe symptoms) with the largest change in score (i.e., treatment impact. Conclusions The GERD-HRQL has proven to be a reliable, responsive and versatile symptom severity instrument for studies involving GERD as a subject. The GERD-HRQL symptom severity instrument was developed and published 25 years ago. This seems like an apropos time to review how the instrument has been used in the "real-world." Google Scholar, PubMed, and Web of Science websites search was done using the keywords "GERD-HRQL" or its author, "Velanovich." Once articles were identified, the following information was obtained from each article: first author name, country of origin, journal published, year of publications, type of study design, subject of study, category of study, disease type studied, purpose of the study, how the GERD-HRQL scores were reported, how the GERD-HRQL scores were statistically reported, and results of the study. The total and change of scores were analyzed for descriptive statistics based on disease process studied and intervention studied. A total of 767 articles by 562 different first authors were identified in 193 different journals from 53 different countries of study origin. After a period of steady usages, the number of publication employing the GERD-HRQL has rapidly increase over the last 5 years. There have been 8 validated translations into other languages, although there appears to be numerous, non-validated ad hoc translations. Most commonly used or studied: observational cohort study design, surgical treatment study category, GERD disease process, treatment effect study purpose, total GERD-HRQL scores reported as means or medians. However, there were a wide variety of other study designs, study categories, disease processes, and study purposes. In general, GERD and laryngopharyngeal reflux had the high pre-treatment scores (i.e., more severe symptoms), and surgical and endoscopic interventions the lowest post-treatment score (i.e., least severe symptoms) with the largest change in score (i.e., treatment impact. The GERD-HRQL has proven to be a reliable, responsive and versatile symptom severity instrument for studies involving GERD as a subject. |
Author | Velanovich, Vic |
Author_xml | – sequence: 1 givenname: Vic orcidid: 0000-0003-0133-948X surname: Velanovich fullname: Velanovich, Vic email: vvelanov@usf.edu organization: The Division of Gastrointestinal Surgery, University of South Florida Morsani College of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35920907$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc9rFTEQx4NU7Gv1H_AgAS9eovm52XiTtrbCA2mph14asvsSm7KbXTNZ4f335vW1CD30NAx8PsPMfI_QQZqSR-g9o58ZpfoLUCobSSjnhBrZCGJeoRWTghPOWXuAVtQISrg28hAdAdzTyhum3qBDoQynhuoVuuUK33iXAU8BlzuPz8-uTsnF1eUaw3acyzRi8H99jmWLY4KSl9Gn8hW7hB2AB9i1O3deuiHCnd9gN89D7F2JU4K36HVwA_h3j_UY_fp-dn1yQdY_z3-cfFuTXlBViJQsMENVI1XXa6Wlb7xvWiacEB112vFOihBk6Hi_URsuWGhZaDqpnTCt1uIYfdrPnfP0Z_FQ7Bih98Pgkp8WsLwxutFSM1bRj8_Q-2nJqW5nuW5U_RyjolIfHqmlG_3GzjmOLm_t0-cq0O6BPk8A2Qfbx_JwdMkuDpZRuwvJ7kOyNST7EJI1VeXP1KfpL0piL0GF02-f_6_9gvUPfN2h8w |
CitedBy_id | crossref_primary_10_1007_s11695_024_07082_y crossref_primary_10_1038_s41598_024_76330_z crossref_primary_10_1159_000536566 crossref_primary_10_1007_s00464_024_11415_4 crossref_primary_10_1097_JS9_0000000000002124 crossref_primary_10_5056_jnm23088 crossref_primary_10_1136_bmjgast_2023_001298 crossref_primary_10_1177_26345161231211769 crossref_primary_10_1007_s00464_024_11176_0 crossref_primary_10_1136_bmjopen_2024_088970 crossref_primary_10_1007_s11695_024_07385_0 crossref_primary_10_23736_S2724_5691_23_10230_9 crossref_primary_10_57187_s_3365 crossref_primary_10_1007_s11695_023_06636_w crossref_primary_10_5056_jnm23063 crossref_primary_10_5056_jnm23150 crossref_primary_10_1007_s11695_024_07610_w crossref_primary_10_1016_j_imr_2023_100971 |
Cites_doi | 10.1590/S0004-28032004000400012 10.1155/2020/5415813 10.1007/s11605-016-3342-5 10.1590/S0004-28032007000200016 10.1111/j.1442-2050.2007.00658.x 10.1097/MEG.0000000000001914 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 |
DOI | 10.1007/s00464-022-09463-9 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-2218 |
EndPage | 265 |
ExternalDocumentID | 35920907 10_1007_s00464_022_09463_9 |
Genre | Journal Article Observational Study |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 123 199 1N0 1SB 203 28- 29Q 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67Z 6NX 6PF 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAQQT AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFJLC AFKRA AFLOW AFQWF AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG EX3 F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LLZTM M1P M4Y MA- N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK8 WOW YLTOR Z45 Z7U Z7X Z82 Z83 Z87 Z88 Z8O Z8R Z8V Z8W Z91 Z92 ZMTXR ZOVNA ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY 7XB 8FK K9. PKEHL PQEST PQUKI 7X8 PUEGO |
ID | FETCH-LOGICAL-c305t-441f1905645bc7574e6ee6813a33b0a7a2b43ff4fb2cd5d231f81f6b47a398773 |
IEDL.DBID | 7X7 |
ISSN | 0930-2794 1432-2218 |
IngestDate | Sun Aug 24 03:59:01 EDT 2025 Fri Jul 25 02:51:58 EDT 2025 Mon Jul 21 05:50:47 EDT 2025 Thu Apr 24 22:56:57 EDT 2025 Tue Jul 01 03:24:06 EDT 2025 Fri Feb 21 02:45:11 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Antireflux treatments The GERD-HRQL symptom severity instrument Patient-reported outcomes Quality-of-life instrument Gastroesophageal reflux disease |
Language | English |
License | 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c305t-441f1905645bc7574e6ee6813a33b0a7a2b43ff4fb2cd5d231f81f6b47a398773 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
ORCID | 0000-0003-0133-948X |
PMID | 35920907 |
PQID | 2765218103 |
PQPubID | 31812 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2697674711 proquest_journals_2765218103 pubmed_primary_35920907 crossref_citationtrail_10_1007_s00464_022_09463_9 crossref_primary_10_1007_s00464_022_09463_9 springer_journals_10_1007_s00464_022_09463_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20230100 2023-01-00 20230101 |
PublicationDateYYYYMMDD | 2023-01-01 |
PublicationDate_xml | – month: 1 year: 2023 text: 20230100 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: Germany |
PublicationSubtitle | And Other Interventional Techniques |
PublicationTitle | Surgical endoscopy |
PublicationTitleAbbrev | Surg Endosc |
PublicationTitleAlternate | Surg Endosc |
PublicationYear | 2023 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Rahimi, Tavakol (CR16) 2018; 6 CR4 CR3 Velanovich, Vallance, Gusz (CR1) 1996; 183 Velanovich (CR2) 2007; 20 Balla, Leone, Ribichini (CR5) 2021; 33 Ionova, Nikitina, Mayevskaya (CR8) 2020; 92 CR9 Fernandez, Dore, Velanovich (CR10) 2017; 21 Lechien, Debie, Mahillon (CR14) 2019; 15 Pereira, Costa, Geocze (CR7) 2007; 44 Dua, DeWitt, Kressler (CR13) 2019; 90 Fornari, Crubes, Lopes (CR6) 2004; 41 Diniz, Nesi, Curi, Martins (CR11) 2014; 114 Luo, Hu, Chen (CR12) 2020 Altwigry, Almutairi, Ahmed (CR15) 2017; 11 KS Dua (9463_CR13) 2019; 90 GL Pereira (9463_CR7) 2007; 44 TJ Ionova (9463_CR8) 2020; 92 B Fernandez (9463_CR10) 2017; 21 9463_CR9 Z Luo (9463_CR12) 2020 V Velanovich (9463_CR1) 1996; 183 AM Altwigry (9463_CR15) 2017; 11 JR Lechien (9463_CR14) 2019; 15 LR Diniz (9463_CR11) 2014; 114 9463_CR4 9463_CR3 A Balla (9463_CR5) 2021; 33 F Fornari (9463_CR6) 2004; 41 H Rahimi (9463_CR16) 2018; 6 V Velanovich (9463_CR2) 2007; 20 |
References_xml | – volume: 90 start-page: 74.e3 issue: 64 year: 2019 ident: CR13 article-title: A phase III, multicenter, prospective, single-blinded, non-inferiority, randomized controlled trial on the performance of a novel esophageal stent with an antireflux valve (with video) publication-title: Gastrointest Endosc – volume: 41 start-page: 263 year: 2004 end-page: 267 ident: CR6 article-title: Symptom’s questionnaire for gastroesophageal reflux disease (Brazilian Portuguese) publication-title: Arq Gastroenterol doi: 10.1590/S0004-28032004000400012 – year: 2020 ident: CR12 article-title: Effect of catgut embedment in Du Meridian Acupoint on mental and psychological conditions of patients with gastroesophageal reflux disease publication-title: Evid Based Complem Alternat Med doi: 10.1155/2020/5415813 – volume: 21 start-page: 842 year: 2017 end-page: 895 ident: CR10 article-title: Patient-centered outcomes in surgical research and practice publication-title: J Gastrointest Surg doi: 10.1007/s11605-016-3342-5 – volume: 92 start-page: 59 year: 2020 end-page: 66 ident: CR8 article-title: Testing and validation of the Russian version of quality of life questionnaire in patients with GERD—GERD-HRQL (Russian) publication-title: Ter Arkh – ident: CR3 – ident: CR4 – volume: 183 start-page: 217 year: 1996 end-page: 224 ident: CR1 article-title: Quality of life scale for gastroesophageal reflux disease publication-title: J Am Coll Surg – volume: 15 start-page: 145561319 year: 2019 ident: CR14 article-title: A 10 year follow-up of a randomized prospective study of 2 treatments for chronic rhinosinusitis without nasal polyps and investigation of the impact of gastroesophageal reflux disease in the resistance to treatment publication-title: Ear Nose Throat J – volume: 6 start-page: 213 year: 2018 end-page: 219 ident: CR16 article-title: Effects of Ramadan fasting on the symptoms of gastroesophageal reflux disease publication-title: J Nutr Fasting Health – volume: 44 start-page: 168 year: 2007 end-page: 177 ident: CR7 article-title: Cross-cultural adaptation and validation for Portuguese (Brasil) of the health related quality of life instrument specific for gastroesophageal reflux disease (Brazilian Portuguese) publication-title: Arq Gastroenterol doi: 10.1590/S0004-28032007000200016 – volume: 114 start-page: 180 year: 2014 end-page: 188 ident: CR11 article-title: Qualitative evaluation of osteopathic manipulation therapy in a patient with gastroesophageal reflux disease: a brief report publication-title: J Am Osteopath Assoc – ident: CR9 – volume: 11 start-page: 59 year: 2017 end-page: 64 ident: CR15 article-title: Gastroesophageal reflux disease prevalence among schoolteachers of Saudi Arabia and its impact on their daily activities publication-title: Int J Health Sci – volume: 20 start-page: 130 year: 2007 end-page: 134 ident: CR2 article-title: The development of the GERD-HRQL symptom severity instrument publication-title: Dis Esophagus doi: 10.1111/j.1442-2050.2007.00658.x – volume: 33 start-page: 339 year: 2021 end-page: 345 ident: CR5 article-title: Gastroesophageal reflux disease-health related quality of life questionnaire: prospective development and validation in Italian publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0000000000001914 – volume: 41 start-page: 263 year: 2004 ident: 9463_CR6 publication-title: Arq Gastroenterol doi: 10.1590/S0004-28032004000400012 – volume: 114 start-page: 180 year: 2014 ident: 9463_CR11 publication-title: J Am Osteopath Assoc – ident: 9463_CR4 – ident: 9463_CR9 – volume: 90 start-page: 74.e3 issue: 64 year: 2019 ident: 9463_CR13 publication-title: Gastrointest Endosc – volume: 92 start-page: 59 year: 2020 ident: 9463_CR8 publication-title: Ter Arkh – volume: 6 start-page: 213 year: 2018 ident: 9463_CR16 publication-title: J Nutr Fasting Health – volume: 183 start-page: 217 year: 1996 ident: 9463_CR1 publication-title: J Am Coll Surg – volume: 21 start-page: 842 year: 2017 ident: 9463_CR10 publication-title: J Gastrointest Surg doi: 10.1007/s11605-016-3342-5 – volume: 11 start-page: 59 year: 2017 ident: 9463_CR15 publication-title: Int J Health Sci – volume: 33 start-page: 339 year: 2021 ident: 9463_CR5 publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0000000000001914 – volume: 15 start-page: 145561319 year: 2019 ident: 9463_CR14 publication-title: Ear Nose Throat J – volume: 44 start-page: 168 year: 2007 ident: 9463_CR7 publication-title: Arq Gastroenterol doi: 10.1590/S0004-28032007000200016 – volume: 20 start-page: 130 year: 2007 ident: 9463_CR2 publication-title: Dis Esophagus doi: 10.1111/j.1442-2050.2007.00658.x – ident: 9463_CR3 – year: 2020 ident: 9463_CR12 publication-title: Evid Based Complem Alternat Med doi: 10.1155/2020/5415813 |
SSID | ssj0004915 |
Score | 2.4828515 |
Snippet | Background
The GERD-HRQL symptom severity instrument was developed and published 25 years ago. This seems like an apropos time to review how the instrument has... The GERD-HRQL symptom severity instrument was developed and published 25 years ago. This seems like an apropos time to review how the instrument has been used... BackgroundThe GERD-HRQL symptom severity instrument was developed and published 25 years ago. This seems like an apropos time to review how the instrument has... The GERD-HRQL symptom severity instrument was developed and published 25 years ago. This seems like an apropos time to review how the instrument has been used... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 255 |
SubjectTerms | Abdominal Surgery Endoscopy Gastroenterology Gastroesophageal reflux Gynecology Hepatology Humans Language Laryngopharyngeal Reflux Medical research Medicine Medicine & Public Health Original Article Patients Proctology Quality of Life Quantitative psychology Surgery Surveys and Questionnaires Treatment Outcome |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bSx0xEB6sQumLeGnreiOFvtnAbq4b38TbQbRQ8YC-uCS7CQi658A5PvjvnexNi1bo8ybZZWay8yUz8w3Az0rnQZbCUlEqRYXyguboKChiZ1sGVznJY73zxW81Gouza3ndFYXN-mz3PiTZ_KmHYrcmCkdj9jkeSRSn5hMsyXh2Ryses4OXakjT9i0wPKUMza0rlXl_jb_d0RuM-SY-2ridkxVY7vAiOWgVvAoLvl6DzxddRHwdbpkkN2itMzIJBMEcOT2-PKKjyz_nZPb0MJ1PHgj6Ph9b1JG7hi02XgfuE1sTO5ByxrnTLj--Iq9j2l9hfHJ8dTiiXc8EWuLOnVNENwF9fOSIcaWWWnjlvcozbjl3qdWWOcFDEMGxspIVoruQZ0E5oS03udb8GyzWk9pvAPFG-TTCE5Z5IUNAeQpndWVYHrxwIoGsF11RdoTisa_FfTFQITfiLlDcRSPuwiSwN8yZtnQaH47e7jVSdFtrVjCtZMQlKU_gx_AYN0WMdNjaTx5xjDKRpEhnWQLfW00Or-PSsNSkOoFfvWpfFv_3t2z-3_At-BIb07eXNduwiOr1Owhf5m63sdZn1Lnirw priority: 102 providerName: Springer Nature |
Title | 25 Years of the GERD-HRQL symptom severity instrument: an assessment of published applications |
URI | https://link.springer.com/article/10.1007/s00464-022-09463-9 https://www.ncbi.nlm.nih.gov/pubmed/35920907 https://www.proquest.com/docview/2765218103 https://www.proquest.com/docview/2697674711 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEB_0DsQX8due5xHBNw22-Wx8kVX3blHv0MWFvRdL0iYgeO0euz743ztps13l8J4KbdKGmUnm1_kEeNHoMshaWCpqpahQXtASFQVF7Gzr4Bonecx3Pj1Ts4X4uJTLZHBbp7DK7ZnYH9RNV0cb-WumlYzqKOdvV5c0do2K3tXUQuMm7MfSZTGkSy_1Li_SDB0MDM8pQ8FLSTN96lzv06Mxlh1_cBSn5l_FdAVtXvGU9gro-C7cSciRTAZW34Mbvr0Pt06Tb_wBfGeSnKPcrkkXCMI6cjKdf6Cz-dfPZP37YrXpLghqQR-b1ZEffd3YaBh8Q2xL7FieM85dpUj5hvzt3X4Ii-Ppt_czmron0Br38IYizgmo7WO1GFdrqYVX3quy4JZzl1ttmRM8BBEcqxvZIM4LZRGUE9pyU2rNH8Fe27X-CRBvlM8jUGGFFzIEpKdwVjeGlcELJzIotqSr6lRaPHa4-FmNRZF7cldI7qond2UyeDnOWQ2FNa4dfbjlSJU22braiUQGz8fHuD2iz8O2vvuFY5SJ5Yp0UWTweODk-DkuDctNrjN4tWXt7uX_X8vB9Wt5CrdjS_rBTHMIe8hO_wyBy8Yd9dJ5BPuTk_NPU7y-m559mePdBZv8AWly6ck |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcUHmVQAEjwQmsJrZjJ5WqCuiWLd1dwaqVyoXUTmwJiSaLdhHqn-I3Ms5rQRW99RzbsWbGnm88L4CXhUpcnAtNRS4lFdIKmqCioIidde5MYWLu850nUzk6ER9P49M1-N3lwviwyu5OrC_qosr9G_k2UzL26ijke_Mf1HeN8t7VroVGIxZH9uIXmmyL3cN95O8rxg6Gx-9HtO0qQHOU7SVF_e9QC_oqKiZXsRJWWiuTiGvOTaiVZkZw54QzLC_iAvGPSyInjVCao4GuOK57A9YFR1NmAOvvhtNPs1UmZtr0TEh5SBmKepumUyfr1V5E6qPn0aSSnKb_qsJL-PaSb7ZWeQcbcKfFquRtI1x3Yc2W9-DmpPXG34evLCZfkCQLUjmCQJJ8GM726Wj2eUwWF-fzZXVOUO9a3x6PfKsr1fqnyB2iS6L7gqB-7ryNzS_I3_70B3ByLZR9CIOyKu0jIDaVNvTQiEVWxM4hPYXRqkhZ4qwwIoCoI12Wt8XMfU-N71lfhrkmd4bkzmpyZ2kAr_s586aUx5WjtzqOZO2xXmQrIQzgRf8ZD6T3sujSVj9xjEx9gSQVRQFsNpzsf8fjlIVpqAJ407F2tfj_9_L46r08h1uj48k4Gx9Oj57AbYYwrHkk2oIBstY-Rdi0NM9aWSVwdt3H4w8EniME |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1baxQxFD7UCsUX8e5o1Qj6pKEzuc4IRcTturUXtFjYvnSazCRQaGdWdkX61_x1PZnbKsW-9XmSTDiXnC85N4A3pU69LISholCKCuUETdFQUMTOpvC2tJKHfOe9fTU5FF-ncroCf_pcmBBW2Z-JzUFd1kV4I99gWslgjmK-4buwiG-j8cfZTxo6SAVPa99OoxWRHXfxG69v883tEfL6LWPjrR-fJ7TrMEALlPMFRSzg0SKGiiq20FILp5xTacIN5zY22jAruPfCW1aUskQs5NPEKyu04XhZ1xzXvQW3NZdJ0DE91cuczKztnpDxmDIU-i5hp0nba_yJNMTR4-VKcZr9axSvIN0rXtrG-I3vwd0OtZJPrZjdhxVXPYC1vc4v_xCOmSRHSJA5qT1BSEm-bB2M6OTg-y6ZX5zPFvU5QQvsQqM8ctrUrA2Pkh-IqYgZSoOGubMuSr8kf3vWH8HhjdD1MaxWdeWeAnGZcnEASSxxQnqP9BTW6DJjqXfCigiSnnR50ZU1D901zvKhIHND7hzJnTfkzrMI3g1zZm1Rj2tHr_ccyTsFn-dLcYzg9fAZVTP4W0zl6l84RmWhVJJOkgietJwcfsdlxuIs1hG871m7XPz_e3l2_V5ewRoqRb67vb_zHO4wxGPta9E6rCJn3QvETwv7shFUAic3rRmXwL8l1A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=25+Years+of+the+GERD-HRQL+symptom+severity+instrument%3A+an+assessment+of+published+applications&rft.jtitle=Surgical+endoscopy&rft.au=Velanovich%2C+Vic&rft.date=2023-01-01&rft.pub=Springer+Nature+B.V&rft.issn=0930-2794&rft.eissn=1432-2218&rft.volume=37&rft.issue=1&rft.spage=255&rft.epage=265&rft_id=info:doi/10.1007%2Fs00464-022-09463-9&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0930-2794&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0930-2794&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0930-2794&client=summon |